Pioglityazone and Imatinib for CML Patients

Clinical trial NCT02888964 · COMPLETED

Trial details

NCT number: NCT02888964
Sponsor: Versailles Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic-Phase

Start date: 2009-12-01
Primary completion: 2012-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.